Nurses' roles in CAR-T therapy for B-cell malignancies and managing associated cytokine release syndrome
Asia-Pacific Journal of Oncology Nursing, ISSN: 2347-5625, Vol: 11, Issue: 2, Page: 100367
2024
- 14Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures14
- Readers14
- 14
- Mentions1
- News Mentions1
- News1
Most Recent News
Connecting Patients With Multiple Myeloma to Larger Institutions for CAR T-Cell Therapy
Nurses at local and specialized centers can work together to create a pathway for patients throughout treatment. Over the 30 years Beth Faiman, PhD, MSN,
Review Description
In recent times, significant innovations have been made in cancer immunotherapy. These innovations have yielded positive outcomes, including a substantial improvement in the clinical outcomes of cancer patients, especially in the B-cell setting involving patients with B-cell malignancies. This paper explores oncology nurses’ actual and expanded roles in utilizing chimeric antigen receptor T-cell (CAR-T) therapy. CAR-T therapy is an exciting innovation in cancer treatment. However, this therapy is often associated with some mild to life-threatening side effects and toxicities, including cytokine release syndrome (CRS). Unfortunately, nurses lack adequate standardized guidelines for monitoring and managing patients with CRS. This paper explains oncology nurses’ actual and expanded roles in utilizing CAR-T therapy in treating B-cell malignancies based on experience and published data. Nurses’ responsibilities for patients experiencing CAR-T toxicities with a particular focus on CRS during treatment are discussed.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2347562523001920; http://dx.doi.org/10.1016/j.apjon.2023.100367; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85183022980&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/38304228; https://linkinghub.elsevier.com/retrieve/pii/S2347562523001920; https://dx.doi.org/10.1016/j.apjon.2023.100367
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know